Evidence map›Paper›PMID 36742079›Full record

ArticleLancet regional health. Americas2023

Development of a multivariable prediction model for anal high-grade squamous intraepithelial lesions in persons living with HIV in Puerto Rico: a cross-sectional study.

Marievelisse Soto-Salgado, Erick Suárez, Tariz D Viera-Rojas, Luis R Pericchi, Jeslie M Ramos-Cartagena, Ashish A Deshmukh, Maribel Tirado-Gómez, Ana Patricia Ortiz

Open access · goldAbstract read
In one paragraph

Article in Lancet regional health. Americas, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Marievelisse Soto-SalgadoDivision of Cancer Control and Population Sciences, University of Puerto Rico (UPR) Comprehensive Cancer Center, San Juan, PR, USA.
Erick SuárezDepartment of Biostatistics and Epidemiology, Graduate School of Public Health, UPR Medical Sciences Campus, San Juan, PR, USA.
Tariz D Viera-RojasCancer Prevention and Control Research (CAPAC) Training Program, Division of Cancer Control and Population Sciences, UPR Comprehensive Cancer Center, San Juan, PR, USA.
Luis R PericchiDepartment of Mathematics, Faculty of Natural Sciences, UPR Rio Piedras Campus, PR, USA.
Jeslie M Ramos-CartagenaUPR/MDACC Partnership for Excellence in Cancer Research Program, UPR Medical Sciences Campus, San Juan, PR, USA.
Ashish A DeshmukhDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Maribel Tirado-GómezDivision of Cancer Medicine, UPR Comprehensive Cancer Center, San Juan, PR, USA.
Ana Patricia OrtizDivision of Cancer Control and Population Sciences, University of Puerto Rico (UPR) Comprehensive Cancer Center, San Juan, PR, USA.
University of Puerto Rico, Medical Sciences Campus · PRMedical University of South Carolina · USUniversity of Puerto Rico System · PR

Funding

UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI KAREN J ORTIZ · 2002 to 2026
$36.9M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUCIANO, CARLOS A., RIVERA, ADELMA · 2012 to 2018
$23.2M
Tracking and Evaluation CoreU54GM133807 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI PORTER, JAMES T. · 2020 to 2024
$17.7M
Cancer Prevention and Control (CAPAC) Research Training ProgramR25CA240120 · NCI · COMPREHENSIVE CANCER CENTER/ UNIV/PR · PI ANA Patricia ORTIZ, Marievelisse Soto-Salgado · 2019 to 2026
$2.8M
NCI NIH HHS R25 CA240120NCI NIH HHS U54 CA096297NIGMS NIH HHS U54 GM133807NIMHD NIH HHS U54 MD007587
6 · The paper itself

Abstract

Background: Persons living with HIV (PLWH) are at high risk of developing anal high-grade squamous intraepithelial lesions (HSIL). We aimed to develop a prediction model for anal HSIL based on individual characteristics of PLWH. Methods: Cross-sectional study of PLWH aged ≥21 years who attended the Anal Neoplasia Clinic of the University of Puerto Rico Comprehensive Cancer Center from 2016 to 2022. The primary outcome was biopsy-confirmed anal HSIL. For each sex, relations between potential predictors and HSIL were examined using univariate (ULRM) and multivariable (MLRM) logistic regression models. Risk modelling was performed with MLRM and validated with bootstrapping techniques. The area under the ROC Curves (AUC) was estimated with 95% CI. Findings: HSIL was detected among 45.11% of patients, 68.48% were males, and 59.42% were ≥45 aged. Multivariable analysis showed that, in women, the only significant predictor for HSIL was having a previous abnormal anal cytology (p = 0.01). In men, significant predictors for HSIL were having a previous abnormal anal cytology (p < 0.001) and a history of infection with any gonorrhoea (p = 0.002). Other suggestive predictors for HSIL among women were obesity and smoking. No association between smoking and HSIL among men was observed (p < 0.05). The AUC estimated among women (0.732, 95% CI: 0.651-0.811) was higher than in men (0.689, 95% CI: 0.629-0.748). Interpretation: Our results support that the inclusion of individual characteristics into the prediction model will adequately predict the presence of HSIL in PLWH. Funding: This work was supported by the NCI (Grants #U54CA096297, #R25CA240120), the NIGMS (Grant #U54GM133807), and the NIMHD (Grant #U54MD007587).

Indexed as

Anal HSILEarly detectionHispanicsPersons living with HIVPrediction model

Identifiers

PMID36742079
PMCPMC9894264
OpenAlexW4308348608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.